By contributing within the VEGF/VEGFR2 signaling route, P53 alterations, cell cycle, and PI3K–Akt signaling system, S100A16 may influence the biological processes of RCC, resulting in varied prognoses. Here, TP53 is linked to renal cell carcinoma.